1,3-Dimethylbutylamine
Chemical compound
From Wikipedia, the free encyclopedia
1,3-Dimethylbutylamine (1,3-DMBA, dimethylbutylamine, DMBA, 4-amino-2-methylpentane, or AMP), is a stimulant drug structurally related to methylhexanamine where a butyl group replaces the pentyl group. The compound is an aliphatic amine.
| |||
| Names | |||
|---|---|---|---|
| Preferred IUPAC name
4-Methylpentan-2-amine | |||
| Other names
(4-Methylpentan-2-yl)amine | |||
| Identifiers | |||
3D model (JSmol) |
|||
| ChemSpider | |||
| ECHA InfoCard | 100.003.227 | ||
PubChem CID |
|||
| UNII | |||
CompTox Dashboard (EPA) |
|||
| |||
| |||
| Properties | |||
| C6H15N | |||
| Molar mass | 101.193 g·mol−1 | ||
| Density | 0.717 g/mL[1] | ||
| Boiling point | 108–110 °C (226–230 °F; 381–383 K)[1] | ||
| Pharmacology | |||
| Legal status | |||
| Hazards | |||
| NFPA 704 (fire diamond) | |||
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |||
The hydrochloride and citrate salts of DMBA has been identified as unapproved ingredients in some over-the-counter dietary supplements,[3][4][5] in which it is used in an apparent attempt to circumvent bans on methylhexanamine.[6] The U.S. Food and Drug Administration (FDA) considers any dietary supplement containing DMBA to be "adulterated".[7] Despite the FDA's opposition, DMBA continues to be sold in the US.[8]
There are no known human safety studies on DMBA and its health effects are entirely unknown.[3][4][9]
DMBA is not an agonist of the rodent or human trace amine-associated receptor 1 (TAAR1).[10]



